| Aug 28 |
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
|
| Aug 16 |
Shareholders Will Be Pleased With The Quality of Collegium Pharmaceutical's (NASDAQ:COLL) Earnings
|
| Aug 9 |
Collegium Pharmaceutical: Making Steady Progress
|
| Aug 9 |
Collegium Pharmaceutical: Diversifying And Growing
|
| Aug 9 |
Collegium Pharmaceutical, Inc. (COLL) Q2 2024 Earnings Call Transcript
|
| Aug 9 |
Collegium Pharmaceutical, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 8 |
Collegium Pharmaceutical (COLL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
|
| Aug 8 |
Collegium Pharmaceutical (COLL) Beats Q2 Earnings and Revenue Estimates
|
| Aug 8 |
Collegium Pharmaceutical: Q2 Earnings Snapshot
|
| Aug 8 |
Collegium Pharmaceutical Non-GAAP EPS of $1.62 beats by $0.13, revenue of $145.3M beats by $0.74M
|
